Search results
FDA approves Eli Lilly's treatment which slows symptoms down
Daily Mail· 6 days agoThe US FDA has approved donanemab, a treatment for Alzheimer's disease that helps the body remove...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance UK· 5 days agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
FDA approves second Alzheimer’s drug that can modestly slow disease
Express and Star· 6 days agoThe Food and Drug Administration (FDA) approved Eli Lilly’s Kisunla, known chemically as donanemab,...
British Patient Capital invests £90m London biotech company
CityAM via Yahoo Finance UK· 9 hours agoFund: Breakthrough programme. The funding round was co-led by life science investors Novo Holdings...
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024
Associated Press via Yahoo Finance UK· 6 days agoDigital-media conglomerate IAC is reportedly considering a bid to take control of the owner of CBS and Paramount Studio. Eli Lilly and Co., down $7.66 to ...
Why Is Verve Therapeutics, Inc. (VERV) the Most Shorted Stock Loved by Analysts Now?
Insider Monkey via Yahoo Finance UK· 23 minutes agoWe recently compiled a list of the 10 Most Shorted Stocks That Are Loved by Analysts. In this...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News UK· 5 days agoDonanemab, or Kisunla, is the third drug approved to target one of the causes of Alzheimer’s: the...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance UK· 3 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
CNN.com· 6 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to...
Second drug that slows Alzheimer's approved for use in USA
Liverpool Echo via Yahoo News UK· 6 days agoThe Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of...